4-102506319-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.-8+4531A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.911 in 152,248 control chromosomes in the GnomAD database, including 63,606 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.91 ( 63606 hom., cov: 32)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.332

Publications

28 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.974 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB1NM_003998.4 linkc.-8+4531A>G intron_variant Intron 1 of 23 ENST00000226574.9 NP_003989.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB1ENST00000226574.9 linkc.-8+4531A>G intron_variant Intron 1 of 23 1 NM_003998.4 ENSP00000226574.4
NFKB1ENST00000505458.5 linkc.-8+4152A>G intron_variant Intron 1 of 23 1 ENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.911
AC:
138519
AN:
152130
Hom.:
63545
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.982
Gnomad AMI
AF:
0.974
Gnomad AMR
AF:
0.913
Gnomad ASJ
AF:
0.857
Gnomad EAS
AF:
0.594
Gnomad SAS
AF:
0.742
Gnomad FIN
AF:
0.930
Gnomad MID
AF:
0.883
Gnomad NFE
AF:
0.902
Gnomad OTH
AF:
0.890
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.911
AC:
138638
AN:
152248
Hom.:
63606
Cov.:
32
AF XY:
0.908
AC XY:
67593
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.982
AC:
40771
AN:
41538
American (AMR)
AF:
0.913
AC:
13960
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.857
AC:
2974
AN:
3470
East Asian (EAS)
AF:
0.594
AC:
3067
AN:
5162
South Asian (SAS)
AF:
0.742
AC:
3582
AN:
4830
European-Finnish (FIN)
AF:
0.930
AC:
9874
AN:
10612
Middle Eastern (MID)
AF:
0.884
AC:
260
AN:
294
European-Non Finnish (NFE)
AF:
0.902
AC:
61386
AN:
68020
Other (OTH)
AF:
0.887
AC:
1876
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
591
1182
1773
2364
2955
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
900
1800
2700
3600
4500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.904
Hom.:
102236
Bravo
AF:
0.913
Asia WGS
AF:
0.673
AC:
2339
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.8
DANN
Benign
0.77
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3774934; hg19: chr4-103427476; API